Drug Topics
JULY 2, 2025
In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.
Drug Topics
JULY 11, 2025
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 21, 2025
Panelists discuss how pharmacists should implement follow-up practices for patients who need additional pneumococcal vaccine doses, including scheduling appointments while patients are present, using text or phone reminders, queuing future vaccine prescriptions in computer systems to align with due dates, utilizing state immunization registries for (..)
Drug Topics
JULY 6, 2025
In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Drug Topics
AUGUST 5, 2025
Among rural community pharmacies in the US, researchers explored pneumococcal immunization services, the processes used to identify patient eligibility, and the barriers to vaccine administration.
Drug Topics
JUNE 6, 2025
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Drug Topics
AUGUST 12, 2025
Partnerships between community pharmacists and local primary care providers can help increase the uptake of respiratory syncytial virus (RSV) vaccines, according to recent data published in the journal JAPhA Practice Innovations. Prevention of the disease was previously limited to palivizumab, a costly antibody.
Expert insights. Personalized for you.
Let's personalize your content